Quick Answer
Perspective Therapeutics, Inc. reported Total Assets of $266.97 million for fiscal year 2025.
Perspective Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $266.97M | -21.7% |
| 2024 | $341.10M | +248.4% |
| 2023 | $97.89M | +68.5% |
| 2022 | $58.09M | -9.9% |
| 2022 | $64.44M | -8.5% |
| 2021 | $70.42M | +709.5% |
| 2020 | $8.70M | -7.7% |
| 2019 | $9.42M | +26.4% |
| 2018 | $7.46M | -39.2% |
| 2017 | $12.27M | -32.2% |
| 2016 | $18.10M | -21.3% |
| 2015 | $23.00M | -13.4% |
| 2014 | $26.55M | +276.3% |
| 2013 | $7.06M | -6.0% |
| 2012 | $7.51M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $294.82M | -24.6% | -5.1% |
| June 30, 2025 | $310.73M | -19.5% | -5.7% |
| March 31, 2025 | $329.35M | +18.3% | -3.4% |
| December 31, 2024 | $341.10M | +248.4% | -12.8% |
| September 30, 2024 | $391.15M | +253.9% | +1.4% |
| June 30, 2024 | $385.92M | +221.2% | +38.7% |
| March 31, 2024 | $278.29M | +118.0% | +184.3% |
| December 31, 2023 | $97.89M | +68.5% | -11.4% |
- Perspective Therapeutics, Inc. showed a decrease of -21.7% in Total Assets compared to the prior fiscal year.
- Over the 2012–2025 period, Perspective Therapeutics, Inc.’s total assets has grown by 3457.0% (from $7.51 million to $266.97 million).
- The most recent figure is from Perspective Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: